Page last updated: 2024-09-21

3-nitrobenzonitrile

Cross-References

ID SourceID
PubMed CID12079
CHEMBL ID57012
SCHEMBL ID57152
MeSH IDM0286301

Synonyms (46)

Synonym
EN300-18272
UPCMLD0ENAT5345030:001
m-cyanonitrobenzene
3-cyanonitrobenzene
619-24-9
benzonitrile, 3-nitro-
3-nitrobenzonitrile
nsc-5382
wln: wnr ccn
nsc5382
m-nitrobenzonitrile
benzonitrile, m-nitro-
AC-907/25014352
inchi=1/c7h4n2o2/c8-5-6-2-1-3-7(4-6)9(10)11/h1-4
ai3-16310
ccris 2327
einecs 210-587-7
nsc 5382
3-nitrobenzonitrile, 98%
STK260893
AC-10299
AKOS000304441
CHEMBL57012
3-nitro-benzonitrile
N0170
A833486
3-nitrobenzenecarbonitrile
3-cyano-1-nitrobenzene
FT-0616243
PS-4576
SCHEMBL57152
3-nitrobenzonitril
m-nitrocyanobenzene
3-cyanonitrobenzene-
DTXSID5060697
W-105077
mfcd00007194
12402-46-9
D73176
meta-cyanonitrobenzene
benzonitrile, 3-nitro-, radical ion(1-) (9ci)
CS-0059137
Q63399425
A935271
SY008007
Z57756579

Bioassays (3)

Assay IDTitleYearJournalArticle
AID23714Partition coefficient (logP)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID23978Capacity ratio (log k'w)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID203473Binding constant against bovine serum albumin1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]